Skip to search formSkip to main contentSkip to account menu

advax

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
ABSTRACT Subunit vaccines against anthrax based on recombinant protective antigen (PA) potentially offer more consistent and less… 
Highly Cited
2013
Highly Cited
2013
ABSTRACT West Nile virus (WNV), currently the cause of a serious U.S. epidemic, is a mosquito-borne flavivirus and member of the… 
Highly Cited
2011
Highly Cited
2011
Background DNA-based vaccines have been safe but weakly immunogenic in humans to date. Methods and Findings We sought to… 
Highly Cited
2010
Highly Cited
2010
Advax is a polysaccharide-based adjuvant that potently stimulates vaccine immunogenicity without the increased reactogenicity… 
2010
2010
Background We conducted a Phase I dose escalation trial of ADVAX, a DNA-based candidate HIV-1 vaccine expressing Clade C/B' env…